Rebecca G. Anderson

Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development

Gabriela Rennebeck, Elena Kleymenova, Rebecca G. Anderson et al. · Proceedings of the National Academy of Sciences · 1998 · 106 citations · Full text

A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia

Timothy S. Pardee, Rebecca G. Anderson, Kristin M. Pladna et al. · Clinical Cancer Research · 2018 · 102 citations · Full text

Tight junction protein ZO-2 expression and relative function of ZO-1 and ZO-2 during mouse blastocyst formation

Bhavwanti Sheth, Rachael L. Nowak, Rebecca G. Anderson et al. · Experimental Cell Research · 2008 · 48 citations

Oocyte, Developmental Biology, Oogenesis +9

Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia

Rebecca G. Anderson, Lance D. Miller, Scott Isom et al. · Nature Communications · 2022 · 40 citations · Full text

Pyruvate Dehydrogenase Inhibition Leads to Decreased Glycolysis, Increased Reliance on Gluconeogenesis and Alternative Sources of Acetyl-CoA in Acute Myeloid Leukemia

Rebecca G. Anderson, Kristin M. Pladna, Nathaniel J. Schramm et al. · Cancers · 2023 · 23 citations · Full text